.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
US Department of Justice
Medtronic
Accenture
Teva
Federal Trade Commission
US Army
Chubb
Harvard Business School
Mallinckrodt

Generated: February 19, 2018

DrugPatentWatch Database Preview

Patent Applications for CAPEX

« Back to Dashboard

US Patent Applications for CAPEX

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
➤ Sign Up➤ Sign UpTOPICAL FORMULATIONS COMPRISING SKIN PENETRATION AGENTS AND THE USE THEREOF1999-09-28Patented Case2001-07-19
➤ Sign Up➤ Sign UpFATTY ACID-PHARMACEUTICAL AGENT CONJUGATES2000-12-05Patented Case2003-05-21
➤ Sign Up➤ Sign UpANTIPSORIATIC NAIL POLISH1998-08-18Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622014-03-31
➤ Sign Up➤ Sign UpDevice and active component for inhibiting formation of thrombus-inflammatory cell matrix2000-12-21Abandoned -- Failure to Respond to an Office Action2008-06-06
➤ Sign Up➤ Sign UpAQUEOUS MEDICAMENT PREPARATIONS FOR THE PRODUCTION OF PROPELLENT GAS-FREE AEROSOLS1999-09-15Abandoned -- Failure to Respond to an Office Action2003-07-21
➤ Sign Up➤ Sign UpSPRAY ON BANDAGE AND DRUG DELIVERY SYSTEM2001-02-15Patented Case2003-09-11
➤ Sign Up➤ Sign UpUSE OF AN H+, K+-ATPASE INHIBITOR IN THE TREATMENT OF NASAL POLYPS2001-04-13Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622014-05-26
➤ Sign Up➤ Sign UpBIOCLEAVABLE MICELLE COMPOSITIONS FOR USE AS DRUG CARRIERS2001-04-10Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622009-01-26
➤ Sign Up➤ Sign UpPharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity2001-01-31Abandoned -- Failure to Respond to an Office Action2002-07-26
➤ Sign Up➤ Sign UpUSE OF AN H+, K+-ATPASE INHIBITOR IN THE TREATMENT OF WIDAL'S SYNDROME2001-04-13Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.3622015-08-24
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

WIPO Patent Applications for CAPEX

WIPO Patent Application Title Patent Filing Date
➤ Sign Up
➤ Sign Up
➤ Sign Up
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Farmers Insurance
Julphar
Chinese Patent Office
Harvard Business School
Covington
Mallinckrodt
UBS
Novartis
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot